Ptprn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
PTPRN2 (Protein Tyrosine Phosphatase Receptor Type N2), also known as IA-2beta (Islet Antigen 2 beta), is a receptor-type protein tyrosine phosphatase predominantly expressed in neuroendocrine cells and the nervous system. PTPRN2 is a member of the PTP (protein tyrosine phosphatase) family and is closely related to PTPRN (IA-2). The protein plays important roles in synaptic transmission, hormone secretion, and neuronal signaling. PTPRN2 has been implicated in the pathogenesis of type 1 diabetes, and emerging evidence suggests it may play roles in neurodegenerative diseases through its effects on synaptic function and protein aggregation. [1]
PTPRN2 is a transmembrane receptor-type phosphatase with a large extracellular domain and intracellular catalytic domains. The protein undergoes proteolytic processing to generate a mature form. [2]
PTPRN2 functions as a protein tyrosine phosphatase: [3]
PTPRN2 is highly enriched in synaptic vesicles and participates in: [4]
In neuroendocrine cells, PTPRN2 regulates: [5]
PTPRN2 modulates several signaling pathways:
PTPRN2 was initially identified as an autoantigen in type 1 diabetes:
Evidence suggests PTPRN2 may play roles in AD:
Tau Phosphorylation:
Synaptic Dysfunction:
Amyloid Processing:
In PD, PTPRN2 may contribute through:
PTPRN2 dysfunction may contribute to ALS:
Altered Phosphorylation Balance:
Synaptic Deficits:
Protein Aggregation:
PTPRN2 represents a potential therapeutic target:
Phosphatase Modulation:
Autoimmunity:
Synaptic Protection:
PTPRN2 autoantibodies are:
PTPRN2 interacts with several key proteins:
The study of Ptprn2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Zhang Z, et al. IA-2beta regulates synaptic transmission. Proc Natl Acad Sci USA. 2009. 2009. ↩︎
Wenzler D, et al. Autoantibodies to IA-2 and IA-2beta in type 1 diabetes. Diabetes Care. 2000. 2000. ↩︎
Saller S, et al. Protein tyrosine phosphatases in Alzheimer's disease. J Neurochem. 2010. 2010. ↩︎
Klein M, et al. Synaptic protein tyrosine phosphatases in neurodegeneration. Cell Mol Neurobiol. 2019. 2019. ↩︎
Liu Y, et al. Tyrosine phosphatases in Parkinson's disease. Mol Neurobiol. 2021. 2021. ↩︎